IDH2 and neoplasm: IDH mutations are highly correlated with the degree of intra-tumor heterogeneity, and IDH mutations produce a paracrine metabolite, (R)-2-hydroxyglutarate, which can be involved in shaping the tumor immune microenvironment [146, 147].